Clínica Universidad de Navarra (CUN)
Centro clínico de la Universidad de Navarra
Fred Hutchinson Cancer Research Center
Seattle, Estados UnidosPublicaciones en colaboración con investigadores/as de Fred Hutchinson Cancer Research Center (23)
2021
-
Considerations for treatment duration in responders to immune checkpoint inhibitors
Journal for ImmunoTherapy of Cancer, Vol. 9, Núm. 3
-
Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms
Leukemia, Vol. 35, Núm. 12, pp. 3542-3550
2020
-
A dose-finding Phase 2 study of single agent isatuximab (anti-CD38 mAb) in relapsed/refractory multiple myeloma
Leukemia, Vol. 34, Núm. 12, pp. 3298-3309
-
Evaluating prophylactic heparin in ambulatory patients with solid tumours: a systematic review and individual participant data meta-analysis
The Lancet Haematology, Vol. 7, Núm. 10, pp. e746-e755
-
Low-frequency variation near common germline susceptibility loci are associated with risk of Ewing sarcoma
PLoS ONE, Vol. 15, Núm. 9 September
-
The Khorana score for prediction of venous thromboembolism in cancer patients: An individual patient data meta-analysis
Journal of Thrombosis and Haemostasis, Vol. 18, Núm. 8, pp. 1940-1951
2019
-
A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis
Leukemia, Vol. 33, Núm. 1, pp. 159-170
2018
-
Characterization of male breast cancer: Results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program
Annals of Oncology, Vol. 29, Núm. 2, pp. 405-417
-
Genome-wide association study identifies multiple new loci associated with Ewing sarcoma susceptibility
Nature Communications, Vol. 9, Núm. 1
2016
-
Female chromosome X mosaicism is age-related and preferentially affects the inactivated X chromosome
Nature Communications, Vol. 7
-
Immunodynamics: A cancer immunotherapy trials network review of immune monitoring in immuno-oncology clinical trials
Journal for ImmunoTherapy of Cancer, Vol. 4, Núm. 1
-
International Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal Impairment
Journal of Clinical Oncology, Vol. 34, Núm. 13, pp. 1544-1557
-
Therapeutic impact of cytoreductive surgery and irradiation of posterior fossa ependymoma in the molecular era: A retrospective multicohort analysis
Journal of Clinical Oncology, Vol. 34, Núm. 21, pp. 2468-2477
2015
-
American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma
Biology of Blood and Marrow Transplantation, Vol. 21, Núm. 12, pp. 2039-2051
-
Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types
Journal of the National Cancer Institute, Vol. 107, Núm. 12
-
Carfilzomib, lenalidomide, and dexamethasone for relapsed multiple myeloma
New England Journal of Medicine, Vol. 372, Núm. 2, pp. 142-152
-
Characterization of large structural genetic mosaicism in human autosomes
American Journal of Human Genetics, Vol. 96, Núm. 3, pp. 487-497
2014
-
Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33
Human Molecular Genetics, Vol. 23, Núm. 24, pp. 6616-6633